← Back to Search

U-CHAMP: Urban Cardiovascular Health Assessment and Management Program (U-CHAMP Trial)

N/A
Waitlist Available
Led By Charlotte Jones, PhD, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

High blood pressure, elevated blood glucose and high cholesterol are related to the increased risk of stroke and heart disease. Many studies have shown that this risk can be significantly reduced by lowering blood pressure, blood glucose and cholesterol levels. Through a collaborative effort between Calgary Safeway pharmacists and Calgary Health Region family physician PCN's, U-CHAMP will deliver a program to assist in the identification and management of people with elevated blood pressure, blood glucose and cholesterol and through this effort, reduce the risk of heart disease and stroke in the urban Calgary population aged 18-85 years.

Eligible Conditions
  • Diabetes
  • Cardiovascular Disease
  • High Blood Sugar
  • High Blood Pressure
  • High Cholesterol

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
referral to primary care network for management of blood pressure, lipids and diabetes.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
810 Previous Clinical Trials
886,184 Total Patients Enrolled
3 Trials studying Diabetes
395 Patients Enrolled for Diabetes
University of AlbertaOTHER
942 Previous Clinical Trials
434,289 Total Patients Enrolled
8 Trials studying Diabetes
42,167 Patients Enrolled for Diabetes
Charlotte Jones, PhD, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
66 Total Patients Enrolled
~6 spots leftby Dec 2025